Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BlueRock Therapeutics
Biotech
UK cell programming biotech lays off 25% of staff
The decision was driven by “shifting market conditions” and the need to focus on bit.bio’s “core strengths,” a spokesperson told Fierce Biotech.
Gabrielle Masson
Mar 19, 2025 3:05pm
Bayer moves allogeneic cell therapy into ph. 3 Parkinson's trial
Jan 13, 2025 2:30am
Bayer preps phase 2 after Parkinson's cell therapy scores win
Aug 28, 2023 2:00am
Bayer-owned BlueRock cuts 12% of staff as pipeline contracts
Aug 17, 2023 3:00pm
Bayer's acting BD chief lobbies for the job by making deals
May 24, 2023 3:00am
Bayer's BlueRock taps Rune Labs for Parkinson's study software
Mar 16, 2023 7:00am
